Nariman K. Badr El-Din
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nariman K. Badr El-Din has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Abdelbaset A. El-Aaser
Department of Cancer Biology, National Cancer Institute, University of Cairo, Cairo, Egypt
1 shared publicationHamdy A. Ibrahim
Department of Zoology, Faculty of Science, University of Mansoura, Mansoura, Egypt
1 shared publication- Ibrahim Mohammed El-Sherbiny
Center for Materials Science, Zewail City of Science and Technology, Cairo 12588, Egypt
1 shared publication - Mai Alaa El-Dein
Department of Zoology, Faculty of Science, Mansoura University, Mansoura, Egypt
1 shared publication - Mamdooh Ghoneum
Department of Surgery, Charles Drew University of Medicine and Science, Los Angeles, CA 90059, USA
1 shared publication Mohamed N. El-Bolkainy
Department of Pathology, National Cancer Institute, University of Cairo, Cairo, Egypt
1 shared publication
Latest Publications
- Open Access
- 7 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7953
Enhancement of Anti-Neoplastic Effects of MGN-3/Biobran Against Solid Ehrlich Carcinoma-Bearing Mice via Lipidic Nanoparticle Based Targeted Drug Delivery System
MGN-3 (Biobran), a denatured hemicellulose compound derived from rice bran, possesses potent immunomodulatory and antitumor activity; however, its clinical application is constrained by non-specific tissue distribution, rapid systemic elimination, and poor cellular uptake. To overcome these pharmacological limitations, we engineered MGN-3-loaded lipid nanoparticles (MGN-3.LNPs) formulated with bioactive cinnamon and avocado oils to optimize targeted drug delivery against solid carcinoma. Mice bearing subcutaneous Ehrlich Ascites Carcinoma (EAC) solid tumors received free MGN-3, plain lipid nanoparticles (plain LNPs), or MGN-3.LNPs three times weekly from day 8 to day 26 post-inoculation. The administration of MGN-3.LNPs achieved superior tumor volume suppression (95.00%) compared to free MGN-3 (69.00%) and plain LNPs (63.00%) (p < 0.0001). Mechanistically, MGN-3.LNPs effectively inhibited cancer cell proliferation by suppressing Ki-67 expression while promoting expression shifts that strongly suggest the engagement of mitochondrial-mediated apoptotic signaling, including upregulation of tumor protein p53, Caspase-3, Caspase-9, poly(ADP-ribose) polymerase (PARP), and cytosolic cytochrome c (Cyt c), alongside an elevated Bax/Bcl-2 ratio and reduced 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels. Flow cytometric analysis confirmed that MGN-3.LNPs induced marked G0/G1 cell cycle arrest and promoted sub-G1 apoptotic cell accumulation, which was corroborated by Annexin V/propidium iodide (Annexin V/PI) staining and semiquantitative histopathological evaluation. Furthermore, MGN-3.LNPs downregulated the gene expression of proinflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) while restoring redox homeostasis in tumor tissues. Overall, lipidic nanoencapsulation significantly enhances the therapeutic efficacy of MGN-3 against solid tumors through superior nanoscale tissue penetration, prolonged retention, and synergistic lipid–drug bioactivity.
- 7 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7953
Open AccessEnhancement of Anti-Neoplastic Effects of MGN-3/Biobran Against Solid Ehrlich Carcinoma-Bearing Mice via Lipidic Nanoparticle Based Targeted Drug Delivery System
MGN-3 (Biobran), a denatured hemicellulose compound derived from rice bran, possesses potent immunomodulatory and antitumor activity; however, its clinical application is constrained by non-specific tissue distribution, rapid systemic elimination, and poor cellular uptake. To overcome these pharmacological limitations, we engineered MGN-3-loaded lipid nanoparticles (MGN-3.LNPs) formulated with bioactive cinnamon and avocado oils to optimize targeted drug delivery against solid carcinoma. Mice bearing subcutaneous Ehrlich Ascites Carcinoma (EAC) solid tumors received free MGN-3, plain lipid nanoparticles (plain LNPs), or MGN-3.LNPs three times weekly from day 8 to day 26 post-inoculation. The administration of MGN-3.LNPs achieved superior tumor volume suppression (95.00%) compared to free MGN-3 (69.00%) and plain LNPs (63.00%) (p < 0.0001). Mechanistically, MGN-3.LNPs effectively inhibited cancer cell proliferation by suppressing Ki-67 expression while promoting expression shifts that strongly suggest the engagement of mitochondrial-mediated apoptotic signaling, including upregulation of tumor protein p53, Caspase-3, Caspase-9, poly(ADP-ribose) polymerase (PARP), and cytosolic cytochrome c (Cyt c), alongside an elevated Bax/Bcl-2 ratio and reduced 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels. Flow cytometric analysis confirmed that MGN-3.LNPs induced marked G0/G1 cell cycle arrest and promoted sub-G1 apoptotic cell accumulation, which was corroborated by Annexin V/propidium iodide (Annexin V/PI) staining and semiquantitative histopathological evaluation. Furthermore, MGN-3.LNPs downregulated the gene expression of proinflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) while restoring redox homeostasis in tumor tissues. Overall, lipidic nanoencapsulation significantly enhances the therapeutic efficacy of MGN-3 against solid tumors through superior nanoscale tissue penetration, prolonged retention, and synergistic lipid–drug bioactivity.
- Open Access
- 28 September 2010
- Published by Elsevier in European Journal of Cancer
- Vol. 46 (17) , 3128
“Effect of soybean feeding on experimental carcinogenesis – III. Carcinogenecity of nitrite and dibutylamine in mice: A histopathological study” by Nadia M. Mokhtar, Abdelbaset A. El-Aaser, Mohamed N. El-Bolkainy, Hamdy A. Ibrahim, Nariman K. Badr El-Din and Nagia Z. Moharram European Journal of Cancer Clinical Oncology 24(3) 403–411 (1988)
- 28 September 2010
- Published by Elsevier in European Journal of Cancer
- Vol. 46 (17) , 3128
Open Access“Effect of soybean feeding on experimental carcinogenesis – III. Carcinogenecity of nitrite and dibutylamine in mice: A histopathological study” by Nadia M. Mokhtar, Abdelbaset A. El-Aaser, Mohamed N. El-Bolkainy, Hamdy A. Ibrahim, Nariman K. Badr El-Din and Nagia Z. Moharram European Journal of Cancer Clinical Oncology 24(3) 403–411 (1988)